| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP9
|
aquaporin 9
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CD40LG
|
CD40 ligand
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CLSTN1
|
calsyntenin 1
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTSD
|
cathepsin D
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DCT
|
dopachrome tautomerase
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EYA3
|
EYA transcriptional coactivator and phosphatase 3
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLG
|
filaggrin
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTT2
|
glutathione S-transferase theta 2 (gene/pseudogene)
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
ITM2B
|
integral membrane protein 2B
|
|
KLK1
|
kallikrein 1
|
|
LEP
|
leptin
|
|
LPO
|
lactoperoxidase
|
|
MLH1
|
mutL homolog 1
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
ODC1
|
ornithine decarboxylase 1
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
REN
|
renin
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLC47A2
|
solute carrier family 47 (multidrug and toxin extrusion), member 2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TNF
|
tumor necrosis factor
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
XDH
|
xanthine dehydrogenase
|
